Eli Lilly Corp. buy SVB Leerink LLC
Start price
27.04.26
/
50%
€758.50
Target price
27.04.27
€902.26
Performance (%)
34.53%
Price
14.08.26
€1,020.4
Summary
This prediction is currently active. With a performance of 34.53% the BUY prediction by SVB_Leerink_LLC is a big success. This prediction currently runs until 27.04.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -0.468% | -0.468% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (LLY) had its price target lowered by Leerink Partners from $1,296.00 to $1,058.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€920.00
07.02.26
07.02.26
€1,097.5
07.02.27
07.02.27
10.91%
14.08.26
14.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€807.50
10.11.25
10.11.25
€955.18
10.11.26
10.11.26
26.37%
14.08.26
14.08.26